Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmunoChemistry Technologies is a private life science tools and assay-services company focused on cell viability assays, ELISA reagents, immunohistochemistry reagents, and custom immunoassay development. The company sells research-use products for apoptosis, autophagy, oxidative stress, caspase activity, and related cellular analysis workflows, and also provides assay optimization, protein chemistry, conjugation, purification, and contract laboratory services. Its offerings are aimed at biomedical research, assay developers, and molecular and cellular diagnostics customers rather than therapeutic drug development. ICT appears to operate as part of the broader Antibodies Inc. family of life science brands, with manufacturing and assay support centered in Davis, California. Overall, it is best characterized as an active commercial biotech tools company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImmunoChemistry Technologies.